# Advisor Review - GPT-5.4 (R2)

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-06T16:35:36.335503
**Route:** OpenRouter + LaTeX
**Paper Hash:** 04f31a3527442a68
**Tokens:** 19985 in / 1823 out
**Response SHA256:** c5cd5d2aa46a4208

---

I checked the paper only for fatal errors in data-design alignment, regression sanity, completeness, and internal consistency.

I do **not** find any fatal error that would make the paper impossible or obviously broken at journal submission.

What I checked:

- **Data-design alignment**
  - Treatment dates run from **2015 to 2021**; data run through **2024**, so treatment timing does not exceed data coverage.
  - There are post-treatment observations for the cohorts that begin construction in **2020–2021**, and at least limited post-opening observations for **Line 14 South** after its **June 2024** opening.
  - The treatment definitions used in the text and main regressions are internally consistent enough to be estimable with the stated sample.

- **Regression sanity**
  - No coefficients exceed the fatal thresholds.
  - No standard errors are negative, implausibly huge, or obviously indicative of numerical failure under the stated rules.
  - No impossible reported fit statistics appear.
  - No `NA`, `NaN`, or `Inf` values appear in the regression tables.

- **Completeness**
  - Regression tables report sample sizes or observation counts.
  - Standard errors or confidence intervals are reported.
  - I do not see placeholder entries like `TBD`, `TODO`, `XXX`, or empty numeric cells where results should be.
  - Referenced tables/figures cited in the text appear to exist in the LaTeX source provided.

- **Internal consistency**
  - The main headline estimate in the text matches Table \ref{tab:main}, column (2) reasonably closely.
  - Timing statements are broadly consistent with the sample window.
  - The robustness and mechanism analyses described in the text are actually reported.

ADVISOR VERDICT: PASS